Overview
Complement activation is the triggered, sequential operation of the complement system, a network of plasma and cell-surface proteins that forms a central effector arm of innate immunity. Activation proceeds through three converging routes, the classical, lectin, and alternative pathways, which differ in their initiating recognition events: antibody-antigen complexes, the binding of mannose-binding lectin and related molecules to microbial carbohydrates, and the spontaneous, surface-regulated turnover of complement components. Each pathway converges on the cleavage of central components, generating opsonins that tag pathogens for phagocytosis, anaphylatoxins that promote inflammation and recruit immune cells, and the membrane attack complex that lyses susceptible targets. Tight regulation by inhibitory proteins normally restricts complement to appropriate surfaces, and dysregulated or excessive activation contributes to tissue injury and inflammatory and autoimmune disease, including the inflammatory processes implicated in arthritic joints and in severe infection. Lectin-pathway recognition of carbohydrate structures also links complement to host defense against viruses. The significance of complement activation spans infection, inflammation, autoimmunity, and immunopathology, informing both diagnosis and therapy. Sub-areas include the classical, lectin, and alternative pathways, opsonization, anaphylatoxin signaling, the membrane attack complex, complement regulation, and the role of complement in inflammatory and immune-mediated disease.
Research published in this journal
5 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Exponential Parsimony to Generate Herd Immunity Against SARS- CoV2 Cybernetically Restricting Doxastic and Desiderative Logics
Reducing COVID-19 Risk through Dietary Supplementation of Plant Mannose Binding Lectins
Use of Immune Modulator Interferon-Gamma to Support Combating COVID-19 Pandemic
Total Proteins, β- and γ-globulins as efficacy therapy response indicators in dogs infected with Leishmania infantum – a Review
How this research is being cited
The 5 articles above have been cited 17 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Frontiers in Medicine
-
2023 · Frontiers in Medicine
-
2022 · Biomedicine & Pharmacotherapy
-
2021 · Journal of Clinical Case Studies
-
2021 · Biomedicine & Pharmacotherapy
-
2021 · Cognitive Computation
A sample of recent works citing this journal's research on Complement Activation, linking to each citing work.